MBCCOP, Gulf Coast

Mobile, Alabama 36695

0 studies enrolling now · 104 studies all time

What they study most

Anemia, Anorexia, Anxiety Disorder, Bladder Cancer, Brain Tumors, Brain and Central Nervous System Tumors, Breast Cancer, Cachexia, Cancer-related Problem/Condition, Carcinoma of Unknown Primary, Cardiac Toxicity, Central Nervous System Tumors

Studies at this site

• Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer — Completed
• Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma — Completed
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia — Completed
• Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer — Completed
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer — Completed
• Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy — Completed
• External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer — Completed
• Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme — Completed
• Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme — Completed
• Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum — Completed
• Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer — Completed
• Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases — Completed
• Melatonin and Radiation Therapy in Treating Patients With Brain Metastases — Completed
• Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer — Completed
• Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer — Completed
• Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer — Completed
• Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor — Completed
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma — Completed
• Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer — Completed
• Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer — Completed
• Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors — Completed
• S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma — Completed
• Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord — Completed
• Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer — Completed
• Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma — Completed
• Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer — Completed
• Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer — Completed
• ICI 182780 in Treating Women With Metastatic Breast Cancer — Completed
• Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer — Completed
• A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer — Status unconfirmed
• S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat — Stopped early
• Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer — Completed
• Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme — Completed
• Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer — Completed
• Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer — Completed
• Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy — Completed
• Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial — Completed
• Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer — Completed
• S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer — Completed
• SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial — Completed
• Gabapentin For the Control of Hot Flashes in Women With Breast Cancer — Completed
• Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer — Completed
• Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer — Completed
• Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer — Stopped early
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed
• S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia — Completed
• S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma — Stopped early
• S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome — Completed
• S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia — Completed
• Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer — Completed